Literature DB >> 25416849

Advances in diagnosis and treatment of interstitial cystitis/painful bladder syndrome.

Avinash Chennamsetty1, Michael J Ehlert, Kenneth M Peters, Kim A Killinger.   

Abstract

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a prevalent chronic condition that can be challenging not only to diagnose but also to treat. We review recent diagnostic markers and therapies for IC/BPS from non-medication-based therapies, oral therapies, intravesical therapies, and surgical treatments.

Entities:  

Year:  2015        PMID： 25416849     DOI： 10.1007/s11908-014-0454-5

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


  105 in total

1.  Risk factors that affect the treatment of interstitial cystitis using intravesical therapy with a dimethyl sulfoxide cocktail.

Authors:  Man-Jung Hung; Yi-Ting Chen; Pao-Sheng Shen; Shih-Tien Hsu; Gin-Den Chen; Esther Shih-Chu Ho
Journal:  Int Urogynecol J       Date:  2012-03-17       Impact factor: 2.894

2.  Efficacy of sacral neuromodulation in treatment of bladder pain syndrome: long-term follow-up.

Authors:  Yahya Q Ghazwani; Mohamed S Elkelini; Magdy M Hassouna
Journal:  Neurourol Urodyn       Date:  2011-05-06       Impact factor: 2.696

3.  Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome.

Authors:  Harris E Foster; Philip M Hanno; J Curtis Nickel; Christopher K Payne; Robert D Mayer; David A Burks; Claire C Yang; Toby C Chai; Karl J Kreder; Kenneth M Peters; Emily S Lukacz; Mary P FitzGerald; Liyi Cen; J Richard Landis; Kathleen J Propert; Wei Yang; John W Kusek; Leroy M Nyberg
Journal:  J Urol       Date:  2010-03-29       Impact factor: 7.450

4.  Primary treatment of radiation-induced hemorrhagic cystitis with hyperbaric oxygen: 10-year experience.

Authors:  J P Weiss; D M Mattei; E C Neville; P M Hanno
Journal:  J Urol       Date:  1994-06       Impact factor: 7.450

5.  Nerve growth factor and gastric hyperalgesia in the rat.

Authors:  K Lamb; Y M Kang; G F Gebhart; K Bielefeldt
Journal:  Neurogastroenterol Motil       Date:  2003-08       Impact factor: 3.598

6.  Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor in men with interstitial cystitis versus chronic pelvic pain syndrome.

Authors:  Susan Keay; Chen-Ou Zhang; Toby Chai; John Warren; Kristopher Koch; David Grkovic; Heidi Colville; Richard Alexander
Journal:  Urology       Date:  2004-01       Impact factor: 2.649

Review 7.  Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal.

Authors:  Joop P van de Merwe; Jørgen Nordling; Pierre Bouchelouche; Kirsten Bouchelouche; Mauro Cervigni; L Kurosch Daha; Suzy Elneil; Magnus Fall; Gero Hohlbrugger; Paul Irwin; Svend Mortensen; Arndt van Ophoven; John L Osborne; Ralph Peeker; Benedikte Richter; Claus Riedl; Jukka Sairanen; Martina Tinzl; Jean-Jacques Wyndaele
Journal:  Eur Urol       Date:  2007-09-20       Impact factor: 20.096

8.  Fulguration for Hunner ulcers: long-term clinical outcomes.

Authors:  Joel H Hillelsohn; Soroush Rais-Bahrami; Justin I Friedlander; Zhamshid Okhunov; Mahyar Kashan; Lisa Rosen; Robert M Moldwin
Journal:  J Urol       Date:  2012-10-22       Impact factor: 7.450

9.  DIMETHYL SULFOXIDE (DMSO): A NEW CONCEPT IN PHARMACOTHERAPY.

Authors:  S W JACOB; M BISCHEL; R J HERSCHLER
Journal:  Curr Ther Res Clin Exp       Date:  1964-02

10.  Bladder pain syndrome treated with triple therapy with gabapentin, amitriptyline, and a nonsteroidal anti-inflammatory drug.

Authors:  Jea Whan Lee; Dong Youp Han; Hee Jong Jeong
Journal:  Int Neurourol J       Date:  2010-12-31       Impact factor: 2.835
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.